Industry litigation – Page 21
-
Business
Appeal reverses ECHA call for animal tests
Automotive refrigerant will not need further toxicity studies under the Reach regulation
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
Business
DuPont and Monsanto settle Roundup dispute
Firms drop expensive ongoing litigation in favour of a licensing deal
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Court convicts ex-Aptuit researcher over drug data
Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
-
Business
Dispute over Arkema finances
French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
-
BusinessUK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
Business
Dow rapped for $1bn tax scheme
Judge opines: ‘tax law deals in economic realities, not legal abstractions’
-
Business
Does chemical regulation boost innovation?
Report suggests that supply of innovation responds to extra demand created by new laws
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
BusinessEU proposes neonicotinoid pesticide ban
Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Business
Single EU patent agreed for 2014
European commission says long awaited single patent will cut cost of filing by 87%
-
Business
Roche and the Tamiflu data
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
-
BusinessRecord insider trading case hits pharma
US authorities claim that hedge fund manager made illicit gains of $276 million in response to confidential clinical trial data